Navigation Links
Deloitte Recap Launches New Solution for Clinical Development
Date:11/11/2009

racts to analyze effective royalty rates for deal by stage of development at signing.

"Given the pace of today's rapidly changing biopharmaceutical industry, the Recap IQ Series by Deloitte provides a much needed source for real-time data based on business intelligence to help subscribers make informed strategic decisions, from M&A and alliance formation to clinical development decisions," added Jacques Mulder, a principal with Deloitte Consulting LLP.

About Recap

Originally founded as Recombinant Capital, Inc. in 1988 by Mark Edwards and based in the San Francisco Bay Area. In July 2008, Recombinant Capital, Inc. was purchased by a subsidiary of Deloitte LLP and the business is now known as Deloitte Recap LLC (Recap). Please see www.recap.com for more information about Recap's services. As used in this document, "Recap" means Deloitte Recap LLC and "Deloitte" means Deloitte LLP and Deloitte Services LP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

SOURCE Deloitte


'/>"/>
SOURCE Deloitte
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
3. Advanced Health Media Named to Deloittes 2009 Technology Fast 500(TM)
4. Deloitte Report: Pharmaceutical Companies Patent Cliff Could Bolster Mergers and Acquisitions
5. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
6. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
7. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
8. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
9. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
10. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
11. Premier Micronutrient Launches Supplement for Hearing Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... -- Actavis plc (NYSE: ACT ), a leading global ... CEO and President of Actavis, will provide an overview and ... Healthcare Conference 2014 in New York, NY ... The presentation will take place on Tuesday, September 9, 2014 ... York, 109 East 42 nd Street, New ...
(Date:8/26/2014)... , Aug. 26, 2014 ... report is available in its catalogue: ... to 2020 http://www.reportlinker.com/p02280977/Japan-Esophagoscopes--Gastroscopes-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary ... Market Outlook to 2020", provides key market ...
(Date:8/26/2014)... , Aug. 26, 2014 Research ... "Global Intranasal Drug Delivery Market 2014-2018" report to ... a medical device used for the administration of drugs ... and paranasal sinus such as allergic and non-allergic rhinitis ... ideal administrative route for needle-free vaccination and systematic drug ...
Breaking Medicine Technology:Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 3Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 4Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 5Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3
... 31, 2011 MultiCell Technologies, Inc. (OTC Bulletin Board: ... U.S. patent 7,935,528 by the United States Patent and Trademark ... liver stem cells to treat liver disease.  Under the terms ... is the worldwide exclusive licensee of U.S. patent 7,935,528.   ...
... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... Mr. Kenneth Lee as a director to the Board of ... Xianping Wang who resigned from the Board due to personal ... SAIF Partners, a leading growth capital fund focused on China ...
Cached Medicine Technology:MultiCell Technologies is Granted Stem Cell Patent 2MultiCell Technologies is Granted Stem Cell Patent 3Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:8/27/2014)... of clinical trial participation in the largest ongoing observational ... are not representative of the larger patient base, according ... Dr. Jay Udell. The study authors call into question ... population, and suggest the use of broader enrollment criteria ... "We know that clinical trials can be tremendously expensive ...
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... everyone. To do this, Jaha invested in creating the industry’s ... motivation by adding functions that no other apps possess. ... with a tracker that differentiates in three simple steps: locate, ... will launch on Tuesday, Aug 26, 2014 to garner support ...
(Date:8/27/2014)... 2014 The Global and China Maleic ... the current state of the Maleic Anhydride industry in ... overview of the industry, including definitions, applications and industry ... analysis are provided with a focus on history, developments, ... between the international and Chinese situation is also offered. ...
(Date:8/27/2014)... Do brands know what consumers think of their marketing ... on the topic Sept. 16 when it reveals the results ... Association and the Association of National Advertisers . ... learn what types of marketing messages are the most likable ... decision. While the survey focuses on consumer reaction to radio ...
(Date:8/27/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... PRODUCTS , the global market for advanced orthopedic technology ... to $42.2 billion by 2019, with a compound annual ... New technologies and an increasingly older population are two ... While there are many conventional and generally less expensive ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5Health News:CRN Set To Release Poll Results On What Marketing Tactics Prompt Consumers To Buy 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... say the autism rate in the U.S. is now 1 in ... country know those statistics are inaccurate. , Misdiagnosis is the hottest ... misdiagnosed with autism , a label parents are often pushed ... October 9-11, in 90+ cities around the world, parents will gather ...
... 2009 Golden Apple Awards , CHICAGO, Oct. ... state and local dental societies across the nation with the ... in its 21st year, recognizes outstanding achievement in dental society ... Apple Awards will be presented through the end of the ...
... at Fred Hutchinson Cancer Research Center, Group Health ... of Public Health and Pharmacy have been selected ... million in federal stimulus funding for comparative-effectiveness research ... national hub for conducting such research, which aims ...
... National Institutes of Health announced today a second phase ... funds for 19 research consortia. The Rare Diseases Clinical ... will be awarded a total of just over $117 ... with the new funding will explore the natural history, ...
... widely used for applications that include inventory management, ... luggage security. More recently, these systems have found ... equipment assets and staff members. However, there ... which manufacturers of RFID equipment or medical devices ...
... College of Preventive Medicine (ACPM) supports the recommendations of ... care providers should screen all adults for depression, and ... systems in place to ensure the accurate diagnosis and ... opportunities to identify depression are in the clinics of ...
Cached Medicine News:Health News:Autism Stats Exaggerated: Parents Pushing Back This Weekend 2Health News:ADA Honors State and Local Dental Societies for Their Outreach Programs 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 3Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 4Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 2Health News:NIH announces expansion of Rare Diseases Clinical Research Network 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 4Health News:NIH announces expansion of Rare Diseases Clinical Research Network 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 6Health News:NIH announces expansion of Rare Diseases Clinical Research Network 7Health News:NIH announces expansion of Rare Diseases Clinical Research Network 8Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 2Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 3
... wide Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 15 x 7 cm ... two casting gates, and two 1.5 ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
Medicine Products: